Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc.

CPIX

Get informed when a big investor buys or sells

+ Follow
Market Cap$126.76M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cumberland Pharmaceuticals Inc.Cumberland Pharmaceuticals Inc.-11.817.73%-61%3.40.3
$12.01

Current Fair Value

77.9% upside

Undervalued by 77.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$126.76 Million
Enterprise Value$127.61 Million
Dividend Yield$1.50 (17.73%)
Earnings per Share$-0.19
Beta0.11
Outstanding Shares14,981,607

Return

Return on Equity-60.82%ROE
Return on Assets-16.87%
Return on Invested Capital-35.68%

Valuation & Multiples

P/E Ratio-11.84P/E Ratio
PEG-2.6PEG
Price to Sales3.38Price to Sales
Price to Book Ratio6.75Price to Book Ratio
Enterprise Value to Revenue4.08
Enterprise Value to EBIT-12.92
Enterprise Value to Net Income-13
Total Debt to Enterprise0.04
Debt to Equity0.27Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 11, 2026
EPS Estimate
$-0.13
Average shareholder expectation
Revenue Estimate
$8.57 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 3, 2026
EPS Estimate
$-0.13
Average shareholder expectation
Revenue Estimate
$8.50 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.3869▼ 107.56%
Total Calls108,800▲ 270.07%
Total Puts42,100▼ 2.09%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %18.46%▼ 1.32%
Total Invested$8.97M▼ 23.77%
Investors Holding34▲ 3.00%

ESG Score

No data

About Cumberland Pharmaceuticals Inc.

90 employees

Cumberland Emerging Technologies, Inc.(www.cet-fund.com)is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University, LaunchTN and WinHealth Pharma. The mission of CET is to bring biomedical technologies and produ...